$18.33
0.703.97%
At close: -
$18.93
0.603.28%
After Hours: Apr 25, 5:29 PM EDT
Comments
Loading...
Travere Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TVTX | Benzinga
Travere Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.360
Quarterly Revenue Estimate
$77.50M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$233.18M
Analyze the earnings history of Travere Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics | -$1.51 | -$0.36 | — | — | $41.37M | $77.50M | — | — | 05/01/2025 | Get Alert |
| TVTX | Travere Therapeutics | -$0.94 | -$0.38 | -$0.47 | -23.68% | $45.06M | $72.38M | $74.79M | 3.33% | 02/20/2025 | Get Alert |
| TVTX | Travere Therapeutics | $2.27 | -$0.68 | -$0.46 | 32.35% | $37.09M | $60.48M | $62.90M | 4.00% | 10/31/2024 | Get Alert |
| TVTX | Travere Therapeutics | -$0.79 | -$0.86 | -$0.65 | 24.42% | $59.70M | $50.17M | $52.18M | 4.00% | 08/01/2024 | Get Alert |
| TVTX | Travere Therapeutics | -$0.92 | -$0.99 | -$1.51 | -52.53% | $30.89M | $42.85M | $41.37M | -3.44% | 05/06/2024 | Get Alert |
| TVTX | Travere Therapeutics | -$0.76 | -$1.26 | -$0.94 | 25.40% | $55.87M | $41.51M | $45.06M | 8.55% | 02/15/2024 | Get Alert |
| TVTX | Travere Therapeutics | -$0.86 | — | $2.27 | — | $28.07M | — | $37.09M | — | 11/07/2023 | Get Alert |
| TVTX | Travere Therapeutics | -$0.65 | -$1.16 | -$0.77 | 33.62% | $54.17M | $53.93M | $59.70M | 10.69% | 08/03/2023 | Get Alert |
| TVTX | Travere Therapeutics | -$0.82 | -$1.17 | -$0.82 | 29.91% | $48.49M | $50.61M | $56.99M | 12.61% | 05/04/2023 | Get Alert |
| TVTX | Travere Therapeutics | -$0.61 | -$1.07 | -$0.76 | 28.97% | $57.25M | $53.01M | $55.87M | 5.39% | 02/23/2023 | Get Alert |
| TVTX | Travere Therapeutics | -$0.13 | -$0.89 | -$0.76 | 14.61% | $68.22M | $54.76M | $53.50M | -2.31% | 10/27/2022 | Get Alert |
| TVTX | Travere Therapeutics | -$0.39 | -$0.88 | -$0.65 | 26.14% | $54.62M | $49.63M | $54.17M | 9.14% | 08/04/2022 | Get Alert |
| TVTX | Travere Therapeutics | -$0.55 | -$0.85 | -$0.82 | 3.53% | $47.41M | $51.92M | $48.49M | -6.61% | 05/05/2022 | Get Alert |
| TVTX | Travere Therapeutics | -$0.48 | -$0.72 | -$0.61 | 15.28% | $50.98M | $57.81M | $57.25M | -0.97% | 02/24/2022 | Get Alert |
| TVTX | Travere Therapeutics | -$0.11 | -$0.54 | -$0.13 | 75.93% | $51.14M | $60.93M | $68.22M | 11.96% | 10/28/2021 | Get Alert |
| TVTX | Travere Therapeutics | -$0.22 | -$0.68 | -$0.39 | 42.65% | $48.43M | $50.33M | $54.62M | 8.52% | 07/29/2021 | Get Alert |
| TVTX | Travere Therapeutics | -$0.20 | -$0.39 | -$0.55 | -41.03% | $47.77M | $50.09M | $47.41M | -5.36% | 05/06/2021 | Get Alert |
| TVTX | Travere Therapeutics | -$0.70 | -$0.47 | -$0.48 | -2.13% | $46.69M | $51.66M | $50.98M | -1.31% | 03/01/2021 | Get Alert |
| TVTX | Travere Therapeutics | -$0.66 | -$0.51 | -$0.11 | 78.43% | $44.37M | $48.14M | $51.14M | 6.23% | 11/05/2020 | Get Alert |
| TVTX | Travere Therapeutics | -$0.58 | -$0.55 | -$0.22 | 60.00% | $44.71M | $47.08M | $48.43M | 2.87% | 07/30/2020 | Get Alert |
| TVTX | Travere Therapeutics | -$0.63 | -$0.67 | -$0.20 | 70.15% | $39.57M | $43.43M | $47.77M | 9.99% | 05/11/2020 | Get Alert |
Travere Therapeutics (TVTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-20 | $-0.47 | $-0.38 | -23.7 % |
| Q3 | 2024-10-31 | $-0.46 | $-0.68 | 32.4 % |
| Q2 | 2024-08-01 | $-0.65 | $-0.86 | 24.4 % |
| Q1 | 2024-05-06 | $-1.51 | $-0.99 | -52.5 % |
Travere Therapeutics (TVTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-20 | $74.79M | $72.38M | 3.33 % |
| Q3 | 2024-10-31 | $62.90M | $60.48M | 4.00 % |
| Q2 | 2024-08-01 | $52.18M | $50.17M | 4.00 % |
| Q1 | 2024-05-06 | $41.37M | $42.85M | -3.44 % |
FAQ
When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?
Travere Therapeutics (TVTX) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 20, 2025 for Q4.
What were the latest earnings per share (EPS) for Travere Therapeutics (NASDAQ:TVTX)?
The Actual EPS was $-0.47, which missed the estimate of $-0.38.
What were Travere Therapeutics’s (NASDAQ:TVTX) revenues?
The Actual Revenue was $74.8M, which beat the estimate of $72.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
